Quick Facts
FONT-SIZE Plus   Neg
Share SHARE

Velti To Sell 16.53 Mln Ordinary Shares At Price Of $1.50/shr

Velti plc (VELT: Quote), a provider of mobile marketing and advertising technology and solutions, announced Friday that it has entered into a securities purchase agreement with certain institutional accredited investors to sell 16.53 million ordinary shares at a price of $1.50 per share.

The aggregate gross proceeds of the offering are $24.8 million.

The company noted that it intends to use the proceeds of the offering to pay certain deferred acquisition consideration totaling approximately $16.5 million relating to its November 2011 acquisition of MIG, and for research and development of the company's technology solutions, working capital, and general corporate purposes.

The company stated that it has agreed to file a registration statement registering the securities for resale.

Click here to receive FREE breaking news email alerts for Velti PLC and others in your portfolio

by RTT Staff Writer

For comments and feedback: editorial@rttnews.com

Business News

Quick Facts

Editors Pick
Swiss drug maker Roche Holding said a late-stage trial of its breast cancer drug Kadcyla did not provide superior results compared with an existing therapy. FCA US, until recently known as Chrysler, said Friday it is recalling 257,000 Dodge Ram pickups. The auto maker says the rear axle pinion nut on certain model year 2005 Dodge Ram 1500 trucks may loosen due to an undersized spline on the pinion gear. If the pinion nut loosens, the rear axle may... This medical device company has a very impressive track record of growing business over the past decade. increasing sales from $490.2 million in 2004 to $1.72 billion this year. The Silicone Hydrogel daily disposable lens portfolio constitutes a major avenue for growth.
comments powered by Disqus
FREE Newsletters, Analysis & Alerts

 

Stay informed with our FREE daily Newsletters and real-time breaking News Alerts. Sign up to receive the latest information on business news, health, technology, biotech, market analysis, currency trading and more.